- Home
- PTCT vs GLOB Comparison
PTCT vs GLOB Comparison
Compare PTCT & GLOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTCT
- GLOB
- Stock Information
- Founded
- PTCT 1998
- GLOB 2003
- Country
- PTCT United States
- GLOB Luxembourg
- Employees
- PTCT N/A
- GLOB N/A
- Industry
- PTCT Biotechnology: Pharmaceutical Preparations
- GLOB EDP Services
- Sector
- PTCT Health Care
- GLOB Technology
- Exchange
- PTCT Nasdaq
- GLOB Nasdaq
- Market Cap
- PTCT 4.1B
- GLOB 4.7B
- IPO Year
- PTCT 2013
- GLOB 2014
- Fundamental
- Price
- PTCT $61.09
- GLOB $56.11
- Analyst Decision
- PTCT Buy
- GLOB Buy
- Analyst Count
- PTCT 14
- GLOB 14
- Target Price
- PTCT $67.00
- GLOB $138.71
- AVG Volume (30 Days)
- PTCT 1.4M
- GLOB 1.8M
- Earning Date
- PTCT 11-06-2025
- GLOB 11-13-2025
- Dividend Yield
- PTCT N/A
- GLOB N/A
- EPS Growth
- PTCT N/A
- GLOB N/A
- EPS
- PTCT 7.72
- GLOB 2.44
- Revenue
- PTCT $1,764,929,000.00
- GLOB $2,482,415,000.00
- Revenue This Year
- PTCT $119.89
- GLOB $3.90
- Revenue Next Year
- PTCT N/A
- GLOB $4.14
- P/E Ratio
- PTCT $7.91
- GLOB $22.96
- Revenue Growth
- PTCT 96.00
- GLOB 8.66
- 52 Week Low
- PTCT $31.80
- GLOB $55.91
- 52 Week High
- PTCT $62.18
- GLOB $238.32
- Technical
- Relative Strength Index (RSI)
- PTCT 75.37
- GLOB 24.76
- Support Level
- PTCT $57.47
- GLOB $56.14
- Resistance Level
- PTCT $58.73
- GLOB $64.22
- Average True Range (ATR)
- PTCT 2.04
- GLOB 2.21
- MACD
- PTCT 0.96
- GLOB -0.30
- Stochastic Oscillator
- PTCT 92.16
- GLOB 1.16
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About GLOB Globant S.A.
Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.